Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins. Beijing Hotgen Biotech Co., Ltd. was founded in 2005 and is based in Beijing, China.

Sector

Healthcare

Industry

Biotechnology

CEO

Lin, Changqing

Employees

903

Website

www.hotgen.com.cn

IPO Date

2019-09-30

Headquarters

Zhongguancun High-end Medical Device Ind, Building 10, No. 26 Yongwang West Road, Daxing District, Beijing 102629, China

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Beijing Hotgen Biotech 688068

Beijing Hotgen Biotech Earnings Call Summary

Beijing Hotgen Biotech Earnings

Transcripts

Events

About Beijing Hotgen Biotech Co., Ltd.

Beijing Hotgen Biotech
688068